Bookmark

Add to MyYahoo RSS

Excaliard Pharmaceuticals News

News on Excaliard Pharmaceuticals (Ticker: PFE) continually updated from thousands of sources around the net.

3 hrs ago | Business Journal

Hawaii-based Cardax partners with Capsugel to market astaxanthin

Hawaii-based pharmaceutical company Cardax is partnering with major drug capsule manufacturer Capsugel to mass-produce the anti-inflammatory nutritional supplement called astaxanthin.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Cristiano Ronaldo Ice Bucket Challenge (Funny Version) #IceBucketChallenge

Should the U.S. Capitol Have a POW/MIA Memorial?

Watch A Tortoise Chase Down A Remote-Controlled Truck With ALL ITS MIGHT

This Woman Looks Like She's Wearing Makeup. She's Not.

Mon Aug 18, 2014

Customer Interaction Solutions

Pfizer Submits New Drug Application for Palbociclib ; BioBlast...

Below is a look at some of the headlines for companies that made news in the healthcare sector on August 18, 2014.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Food and Drug Administration

Forbes.com

Interesting June 2015 Stock Options for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Financial Markets

Thu Aug 14, 2014

Customer Interaction Solutions

Pfizer Announces FDA Acceptance Of And Priority Review Designation...

Pfizer Inc. announced today that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for bivalent recombinant LP2086 , the company's vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Food and Drug Administration, Vaccinations, Health

AmericanBankingNews.com

Pfizer PT Lowered to $34.00

Credit Suisse's price target suggests a potential upside of 20.52% from the stock's previous close.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Counterpunch

In the Time of the Shadow Bankers

A practice and loophole that emerged around 2008, US corporate tax 'inversions'-the latest version in a long list of US transnational corporation tax scams-have taken off in 2014.

Comment?

Related Topix: Pfizer, Foldrx Pharmaceuticals

Wed Aug 13, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Entre ellos se destacan los principales actores y protagonistas de la i... )--Hecla Mining Company annonce pour le second trimestre une perte nette attribuable aux actionnaires ordinaires de 14,5 millions de dollars, ou 0,04 $ par action.

Comment?

Related Topix: Clickbank, Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

Tue Aug 12, 2014

Freshnews

Pfizer Reports Top-line Results from Postherpetic Neuralgia and...

Pfizer Inc. announced today top-line results from two placebo-controlled studies conducted in China with Lyrica in patients with postherpetic neuralgia and painful diabetic peripheral neuropathy , respectively.

Comment?

Related Topix: Lyrica, Pregabalin (generic), Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Marketing

Contract Pharma Breaking News

Cytovance Adds Compliance Directors

Mark Ambrose, Ph.D., has been appointed senior director of Quality Systems and Compliance at Cytovance Biologics and Anne Garstka has been named director of Commercial Compliance.

Comment?

Related Topix: Quality Systems, NextGen Healthcare Information Systems, Exton, PA, Pfizer, Foldrx Pharmaceuticals

Mon Aug 11, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Financial Markets

Medical News

Avillion initiates BOSULIF Phase 3 trial in patients with chronic phase Ph+ CML

Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF as a first-line treatment for patients with chronic phase Philadelphia chromosome positive ... (more)

Comment?

Related Topix: Leukemia, Health, Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Fri Aug 08, 2014

Indybay.org

Biotech Dangers, Biotech Workers, Industry And Our Health & And Safety With Becky McClain

Becky McClain, a molecular biologist at Pfizer was fired for making health and safety complaints and then was retaliated against by the company and government officials controlled by Pfizer.

Comment?

Related Topix: Pfizer, Foldrx Pharmaceuticals, Environmental Law, OSHA, Law

Seeking Alpha

Pfizer facing spike of Lipitor lawsuits

Pfizer is facing an increasing amount of lawsuits by women who state that the pharmaceutical giant knew about the serious side effects of its anti-cholesterol drug Lipitor but never adequately warned the public.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Cholesterol, Health, Healthcare Law, Law

Thu Aug 07, 2014

BioSpace

European Medicines Agency Accepts Application Seeking New Indication...

Pfizer Inc. announced today that the European Medicines Agency has accepted Pfizer's application seeking to expand the indication for Prevenar 13* in adults to include the prevention of pneumonia caused by the 13 pneumococcal serotypes contained in the vaccine.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Vaccinations, Health

Wed Aug 06, 2014

Seeking Alpha

Pfizer Cannot Afford GlaxoSmithKline

GSK is too richly valued for Pfizer, and it is more likely that Pfizer will once again pursue AstraZeneca as I predicted earlier.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, GlaxoSmithKline

Tue Aug 05, 2014

BioSpace

Pain Therapeutics Reports Q2 2014 Financial Results

Pain Therapeutics, Inc. today reported financial results for Q2 2014. Net loss in Q2 2014 was $3.2 million, or $0.07 per share, compared to a net loss in Q2 2013 of $0.3 million, or $0.01 per share.

Comment?

Related Topix: Pain Therapeutics, Startups, Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Health, Pain

Seeking Alpha

AstraZeneca Has 30% Upside As A Takeover Candidate

Talks may resume as early as this month if AstraZeneca is interested, but are more likely to resume in November.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Pfizer, Foldrx Pharmaceuticals

Mon Aug 04, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Financial Markets

Business Wire

Rascal Flatts Joins the Thousands of People Who Choose Nexium 24HR...

Starting today, consumers can learn more about the guarantee and high value offer at Nexium24HR.com .

Comment?

Related Topix: Nexium, Esomeprazole (generic), Medicine, Pfizer, Biotech, Healthcare Industry, Foldrx Pharmaceuticals, Marketing

Fri Aug 01, 2014

Seeking Alpha

AstraZeneca's Earnings Beat Reaffirms Bull Thesis

AstraZeneca is attempting to make an earnings comeback after being hindered by a series of patent expirations, which has taken a toll on revenues.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Pfizer, Foldrx Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••